Becton, Dickinson & Co. (BDX)
182.49
-1.85
(-1.00%)
USD |
NYSE |
Feb 24, 16:00
182.49
0.00 (0.00%)
Pre-Market: 08:04
Becton, Dickinson EPS Diluted (Quarterly) : 1.336 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Baxter International, Inc. | -2.160 |
| Abbott Laboratories | 1.030 |
| Boston Scientific Corp. | 0.4493 |
| West Pharmaceutical Services, Inc. | 1.817 |
| Integra LifeSciences Holdings Corp. | -0.0704 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 382.00M |
| Revenue (Quarterly) | 5.252B |
| Total Expenses (Quarterly) | 4.87B |
| Enterprise Value | 70.42B |
| Gross Profit Margin (Quarterly) | 45.91% |
| Profit Margin (Quarterly) | 7.27% |
| Earnings Yield | 3.35% |
| Operating Earnings Yield | 6.18% |
| Normalized Earnings Yield | -0.4202 |